financetom
Business
financetom
/
Business
/
Godrej Consumer Products Q2 sees steady growth in India despite weak macros
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Godrej Consumer Products Q2 sees steady growth in India despite weak macros
Oct 5, 2023 8:15 AM

FMCG major Godrej Consumer Products Ltd (GCPL) on Thursday (October 5) said despite facing challenges such as weak macroeconomic conditions and adverse weather in India, the organic business of the company delivered a steady performance with mid-single digit volume growth in the second quarter ended September 2023.

"In India, we witnessed weak macros and adverse weather conditions during the quarter. Despite the tough operating environment, our organic business delivered a steady performance with mid-single digit volume growth," GCPL said in a regulatory filing.

In specific product segments, home care witnessed mid-single digit volume growth, while personal care achieved growth in the low-single digits. Further, the company noted sequential improvements in the performance of its Park Avenue and KamaSutra brands, indicating that they are on track to meet their full-year guidance.

Beyond Indian borders, GCPL's business in Indonesia continued its upward trajectory, reporting double-digit volume and value growth, underscoring the company's international expansion success.

In the Godrej Africa, USA, and Middle East (GAUM) region, the company maintained its consistent performance, with constant currency sales growth reaching the mid-teens. However, when converted to Indian rupees (INR), adverse currency translation effects are expected to lead to a mid-single-digit decline in sales.

At the consolidated level, on an organic basis, GCPL anticipates mid-single-digit volume growth and double-digit sales growth in constant currency terms. However, due to currency fluctuations, sales growth in rupee terms is projected to be in the low single digits.

The company remains committed to expanding its EBITDA (including forex) margins year-on-year across key markets, while simultaneously increasing investments in category development.

Shares of Godrej Consumer Products Ltd ended at Rs 977.90, down by Rs 12.45, or 1.26 percent, on the BSE.

(Edited by : Shoma Bhattacharjee)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AMC Entertainment Stock Is Rising Monday: What's Going On?
AMC Entertainment Stock Is Rising Monday: What's Going On?
Jul 29, 2024
AMC Entertainment Holdings Inc ( AMC ) shares are on watch higher. The company announced it posted its highest weekend attendance and admissions revenue of 2024. What Happened: AMC announced that it set new 2024 records for weekend attendance and admissions revenue at its U.S. AMC theater locations this past Thursday through Sunday. AMC also set new 2024 records at its...
Acumen Pharmaceuticals Doses First Person in Phase 1 Study of Sabirnetug for Alzheimer's Disease
Acumen Pharmaceuticals Doses First Person in Phase 1 Study of Sabirnetug for Alzheimer's Disease
Jul 29, 2024
11:18 AM EDT, 07/29/2024 (MT Newswires) -- Acumen Pharmaceuticals ( ABOS ) said Monday it has dosed the first person with a subcutaneous formulation of sabirnetug in a phase 1 study of the drug to potentially treat early Alzheimer's disease. The trial will compare the pharmacokinetic between subcutaneous and intravenous administrations of the candidate drug in healthy people, the company...
Why Loop Media Stock Is Up
Why Loop Media Stock Is Up
Jul 29, 2024
Loop Media, Inc. ( LPTV ) shares are trading higher Monday after the company announced a content partnership with Red Bull and the launch of the Red Bull TV channel in all of Loop’s out-of-home venues nationwide.  The Details: Loop Media ( LPTV ) said the Red Bull TV channel is immediately available and offers action sports and sports-related culture...
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
FDA Puts Brake On vTv Therapeutics' Diabetes Candidate Program, Including Late-Stage Study, Stock Tanks
Jul 29, 2024
vTv Therapeutics Inc. ( VTVT ) stock is trading lower on Monday. The FDA has placed a clinical hold on the cadisegliatin clinical program, which includes the ongoing CATT1 Phase 3 trial in type 1 diabetes.  Cadisegliatin is an oral, liver-selective, glucokinase activator. The company says the drug candidate has been well-tolerated in over 500 subjects to date with up to six...
Copyright 2023-2026 - www.financetom.com All Rights Reserved